OASMY
Price
$0.05
Change
-$0.00 (-0.00%)
Updated
Nov 14 closing price
6 days until earnings call
PCLOF
Price
$0.05
Change
-$0.00 (-0.00%)
Updated
Nov 14 closing price
Ad is loading...

OASMY vs PCLOF

Header iconOASMY vs PCLOF Comparison
Open Charts OASMY vs PCLOFBanner chart's image
VIVESTO AB
Price$0.05
Change-$0.00 (-0.00%)
Volume$2K
CapitalizationN/A
PHARMACIELO
Price$0.05
Change-$0.00 (-0.00%)
Volume$500
CapitalizationN/A
OASMY vs PCLOF Comparison Chart
Loading...
View a ticker or compare two or three
VS
OASMY vs. PCLOF commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OASMY is a Hold and PCLOF is a Hold.

COMPARISON
Comparison
Nov 15, 2024
Stock price -- (OASMY: $0.05 vs. PCLOF: $0.05)
Brand notoriety: OASMY and PCLOF are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: OASMY: 20% vs. PCLOF: 4%
Market capitalization -- OASMY: $12.82M vs. PCLOF: $17.67M
OASMY [@Pharmaceuticals: Other] is valued at $12.82M. PCLOF’s [@Pharmaceuticals: Other] market capitalization is $17.67M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OASMY’s FA Score shows that 0 FA rating(s) are green whilePCLOF’s FA Score has 0 green FA rating(s).

  • OASMY’s FA Score: 0 green, 5 red.
  • PCLOF’s FA Score: 0 green, 5 red.
According to our system of comparison, OASMY is a better buy in the long-term than PCLOF.

Price Growth

OASMY (@Pharmaceuticals: Other) experienced а 0.00% price change this week, while PCLOF (@Pharmaceuticals: Other) price change was -10.23% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -5.00%. For the same industry, the average monthly price growth was -7.81%, and the average quarterly price growth was -7.79%.

Reported Earning Dates

OASMY is expected to report earnings on Nov 21, 2024.

Industries' Descriptions

@Pharmaceuticals: Other (-5.00% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

FUNDAMENTALS
Fundamentals
PCLOF($17.7M) has a higher market cap than OASMY($12.8M). OASMY YTD gains are higher at: 150.000 vs. PCLOF (-59.364). PCLOF has higher annual earnings (EBITDA): -11.6M vs. OASMY (-88.39M). OASMY has more cash in the bank: 119M vs. PCLOF (461K). OASMY has less debt than PCLOF: OASMY (7.89M) vs PCLOF (14.3M). PCLOF has higher revenues than OASMY: PCLOF (4.89M) vs OASMY (1.02M).
OASMYPCLOFOASMY / PCLOF
Capitalization12.8M17.7M72%
EBITDA-88.39M-11.6M762%
Gain YTD150.000-59.364-253%
P/E RatioN/AN/A-
Revenue1.02M4.89M21%
Total Cash119M461K25,813%
Total Debt7.89M14.3M55%
FUNDAMENTALS RATINGS
OASMY: Fundamental Ratings
OASMY
OUTLOOK RATING
1..100
35
VALUATION
overvalued / fair valued / undervalued
1..100
39
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
29

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME27.370.91
+3.44%
GameStop Corp
AAPL228.223.10
+1.38%
Apple
SPY593.35-3.84
-0.64%
SPDR® S&P 500® ETF Trust
BTC.X87250.430000-3333.734400
-3.68%
Bitcoin cryptocurrency
TSLA311.18-19.06
-5.77%
Tesla

OASMY and

Correlation & Price change

A.I.dvisor tells us that OASMY and OILFF have been poorly correlated (+7% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OASMY and OILFF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OASMY
1D Price
Change %
OASMY100%
N/A
OILFF - OASMY
7%
Poorly correlated
-13.33%
MRMD - OASMY
4%
Poorly correlated
N/A
MKGAF - OASMY
4%
Poorly correlated
-2.78%
PCLOF - OASMY
2%
Poorly correlated
-6.93%
MVMDF - OASMY
2%
Poorly correlated
-3.75%
More

PCLOF and

Correlation & Price change

A.I.dvisor tells us that PCLOF and MSTH have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PCLOF and MSTH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PCLOF
1D Price
Change %
PCLOF100%
-6.93%
MSTH - PCLOF
23%
Poorly correlated
N/A
OWPC - PCLOF
14%
Poorly correlated
+12.00%
PHCUF - PCLOF
13%
Poorly correlated
N/A
ROMJF - PCLOF
8%
Poorly correlated
+12.43%
OILFF - PCLOF
6%
Poorly correlated
-13.33%
More